Global Spinal Muscular Atrophy (SMA) Treatment Market Insights and Forecast to 2031

Report ID: 1534361 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Type I Spinal Muscular Atrophy (SMA)
        1.2.3 Type II Spinal Muscular Atrophy (SMA)
        1.2.4 Type III Spinal Muscular Atrophy (SMA)
    1.3 Market by Application
        1.3.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Diagnostic Centers
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Perspective (2017-2028)
    2.2 Spinal Muscular Atrophy (SMA) Treatment Growth Trends by Region
        2.2.1 Spinal Muscular Atrophy (SMA) Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Spinal Muscular Atrophy (SMA) Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Spinal Muscular Atrophy (SMA) Treatment Market Dynamics
        2.3.1 Spinal Muscular Atrophy (SMA) Treatment Industry Trends
        2.3.2 Spinal Muscular Atrophy (SMA) Treatment Market Drivers
        2.3.3 Spinal Muscular Atrophy (SMA) Treatment Market Challenges
        2.3.4 Spinal Muscular Atrophy (SMA) Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Spinal Muscular Atrophy (SMA) Treatment Players by Revenue
        3.1.1 Global Top Spinal Muscular Atrophy (SMA) Treatment Players by Revenue (2017-2022)
        3.1.2 Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Spinal Muscular Atrophy (SMA) Treatment Revenue
    3.4 Global Spinal Muscular Atrophy (SMA) Treatment Market Concentration Ratio
        3.4.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy (SMA) Treatment Revenue in 2021
    3.5 Spinal Muscular Atrophy (SMA) Treatment Key Players Head office and Area Served
    3.6 Key Players Spinal Muscular Atrophy (SMA) Treatment Product Solution and Service
    3.7 Date of Enter into Spinal Muscular Atrophy (SMA) Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Spinal Muscular Atrophy (SMA) Treatment Breakdown Data by Type
    4.1 Global Spinal Muscular Atrophy (SMA) Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Type (2023-2028)
5 Spinal Muscular Atrophy (SMA) Treatment Breakdown Data by Application
    5.1 Global Spinal Muscular Atrophy (SMA) Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size (2017-2028)
    6.2 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
        6.2.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022)
        6.2.2 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028)
        6.2.3 North America Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2017-2028)
    6.3 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
        6.3.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022)
        6.3.2 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028)
        6.3.3 North America Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2017-2028)
    6.4 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country
        6.4.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2017-2022)
        6.4.2 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size (2017-2028)
    7.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
        7.2.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022)
        7.2.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028)
        7.2.3 Europe Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2017-2028)
    7.3 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
        7.3.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022)
        7.3.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028)
        7.3.3 Europe Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2017-2028)
    7.4 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country
        7.4.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2017-2022)
        7.4.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
        8.2.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2017-2028)
    8.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
        8.3.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2017-2028)
    8.4 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region
        8.4.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size (2017-2028)
    9.2 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
        9.2.1 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022)
        9.2.2 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028)
        9.2.3 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2017-2028)
    9.3 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
        9.3.1 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022)
        9.3.2 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028)
        9.3.3 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2017-2028)
    9.4 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country
        9.4.1 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2017-2022)
        9.4.2 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
        10.2.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2017-2028)
    10.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
        10.3.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2017-2028)
    10.4 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country
        10.4.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Spinal Muscular Atrophy (SMA) Treatment Introduction
        11.1.4 Pfizer Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
        11.1.5 Pfizer Recent Developments
    11.2 Isis Pharmaceuticals
        11.2.1 Isis Pharmaceuticals Company Details
        11.2.2 Isis Pharmaceuticals Business Overview
        11.2.3 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Introduction
        11.2.4 Isis Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
        11.2.5 Isis Pharmaceuticals Recent Developments
    11.3 Biogen Idec
        11.3.1 Biogen Idec Company Details
        11.3.2 Biogen Idec Business Overview
        11.3.3 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Introduction
        11.3.4 Biogen Idec Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
        11.3.5 Biogen Idec Recent Developments
    11.4 Boehringer Ingelheim
        11.4.1 Boehringer Ingelheim Company Details
        11.4.2 Boehringer Ingelheim Business Overview
        11.4.3 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Introduction
        11.4.4 Boehringer Ingelheim Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
        11.4.5 Boehringer Ingelheim Recent Developments
    11.5 F. Hoffmann-La Roche
        11.5.1 F. Hoffmann-La Roche Company Details
        11.5.2 F. Hoffmann-La Roche Business Overview
        11.5.3 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Introduction
        11.5.4 F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
        11.5.5 F. Hoffmann-La Roche Recent Developments
    11.6 Regeneron Pharmaceuticals
        11.6.1 Regeneron Pharmaceuticals Company Details
        11.6.2 Regeneron Pharmaceuticals Business Overview
        11.6.3 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Introduction
        11.6.4 Regeneron Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
        11.6.5 Regeneron Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Type I Spinal Muscular Atrophy (SMA)
    Table 3. Key Players of Type II Spinal Muscular Atrophy (SMA)
    Table 4. Key Players of Type III Spinal Muscular Atrophy (SMA)
    Table 5. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Region (2017-2022)
    Table 9. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Region (2023-2028)
    Table 11. Spinal Muscular Atrophy (SMA) Treatment Market Trends
    Table 12. Spinal Muscular Atrophy (SMA) Treatment Market Drivers
    Table 13. Spinal Muscular Atrophy (SMA) Treatment Market Challenges
    Table 14. Spinal Muscular Atrophy (SMA) Treatment Market Restraints
    Table 15. Global Spinal Muscular Atrophy (SMA) Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Share by Players (2017-2022)
    Table 17. Global Top Spinal Muscular Atrophy (SMA) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy (SMA) Treatment as of 2021)
    Table 18. Ranking of Global Top Spinal Muscular Atrophy (SMA) Treatment Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Spinal Muscular Atrophy (SMA) Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Spinal Muscular Atrophy (SMA) Treatment Product Solution and Service
    Table 22. Date of Enter into Spinal Muscular Atrophy (SMA) Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2017-2022)
    Table 26. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2023-2028)
    Table 28. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Share by Application (2017-2022)
    Table 30. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Share by Application (2023-2028)
    Table 32. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Pfizer Company Details
    Table 63. Pfizer Business Overview
    Table 64. Pfizer Spinal Muscular Atrophy (SMA) Treatment Product
    Table 65. Pfizer Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million)
    Table 66. Pfizer Recent Developments
    Table 67. Isis Pharmaceuticals Company Details
    Table 68. Isis Pharmaceuticals Business Overview
    Table 69. Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product
    Table 70. Isis Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million)
    Table 71. Isis Pharmaceuticals Recent Developments
    Table 72. Biogen Idec Company Details
    Table 73. Biogen Idec Business Overview
    Table 74. Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Product
    Table 75. Biogen Idec Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million)
    Table 76. Biogen Idec Recent Developments
    Table 77. Boehringer Ingelheim Company Details
    Table 78. Boehringer Ingelheim Business Overview
    Table 79. Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Product
    Table 80. Boehringer Ingelheim Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million)
    Table 81. Boehringer Ingelheim Recent Developments
    Table 82. F. Hoffmann-La Roche Company Details
    Table 83. F. Hoffmann-La Roche Business Overview
    Table 84. F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Product
    Table 85. F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million)
    Table 86. F. Hoffmann-La Roche Recent Developments
    Table 87. Regeneron Pharmaceuticals Company Details
    Table 88. Regeneron Pharmaceuticals Business Overview
    Table 89. Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product
    Table 90. Regeneron Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million)
    Table 91. Regeneron Pharmaceuticals Recent Developments
    Table 92. Research Programs/Design for This Report
    Table 93. Key Data Information from Secondary Sources
    Table 94. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Type I Spinal Muscular Atrophy (SMA) Features
    Figure 3. Type II Spinal Muscular Atrophy (SMA) Features
    Figure 4. Type III Spinal Muscular Atrophy (SMA) Features
    Figure 5. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Application: 2021 VS 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Ambulatory Surgical Centers Case Studies
    Figure 8. Diagnostic Centers Case Studies
    Figure 9. Others Case Studies
    Figure 10. Spinal Muscular Atrophy (SMA) Treatment Report Years Considered
    Figure 11. Global Spinal Muscular Atrophy (SMA) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Spinal Muscular Atrophy (SMA) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Region: 2021 VS 2028
    Figure 14. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Players in 2021
    Figure 15. Global Top Spinal Muscular Atrophy (SMA) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy (SMA) Treatment as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy (SMA) Treatment Revenue in 2021
    Figure 17. North America Spinal Muscular Atrophy (SMA) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type (2017-2028)
    Figure 19. North America Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application (2017-2028)
    Figure 20. North America Spinal Muscular Atrophy (SMA) Treatment Market Size Share by Country (2017-2028)
    Figure 21. United States Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size Share by Country (2017-2028)
    Figure 27. Germany Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size Share by Region (2017-2028)
    Figure 37. China Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size Share by Country (2017-2028)
    Figure 47. Mexico Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Size Share by Country (2017-2028)
    Figure 53. Turkey Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Pfizer Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
    Figure 57. Isis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
    Figure 58. Biogen Idec Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
    Figure 59. Boehringer Ingelheim Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
    Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
    Figure 61. Regeneron Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Isis Pharmaceuticals
Biogen Idec
Boehringer Ingelheim
F. Hoffmann-La Roche
Regeneron Pharmaceuticals
Frequently Asked Questions
Spinal Muscular Atrophy (SMA) Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Spinal Muscular Atrophy (SMA) Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Spinal Muscular Atrophy (SMA) Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Spindle Oil

Spindle Oil market is segmented by Type and by Application. Players, stakeholders, and other part ... Read More

Spirometers

Spirometers market is segmented by Type and by Application. Players, stakeholders, and other part ... Read More

Spirulina Extract

Spirulina Extract market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More